Want to know what’s new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.
Similar Posts
FDA Roundup: May 31, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.Field Science – Laboratory Manual
The Laboratory Manual is a reference manual for FDA personnel. It provides FDA personnel with information on internal procedures to be used as an agency policy for testing consumer products, training of laboratory staff, report writing, safety, research, review of private laboratory reports and courNew Drugs Regulatory Program Modernization: Integrated Assessment of Marketing Applications and Integrated Review Documentation
View details about the NDRP Modernization: Integrated Assessment of Marketing Applications and Integrated Review Documentation; Request for commentsNostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Sucralfate Tablets USP 1 Gram Within Expiry
Nostrum Laboratories, Inc. (“Nostrum Labs”) filed Chapter 11 bankruptcy on September 30, 2024. In connection with that filing, the company has ceased and shutdown operations and terminated its operational employees at all domestic U.S. sites. Nostrum Labs is initiating a voluntary recall of SucralfaIpca Laboratories Limited – 12/5/2025
Ipca Laboratories Limited – 12/5/2025. Country: India. Record Type: 483HimGo may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use HimGo, a product promoted and sold for sexual enhancement on various websites, including ebay.com, and possibly in some retail stores.